US-based Valisure has collaborated with Medly Pharmacy, a full-service, digital pharmacy, to provide Medly customers with Valisure certified drug products, it was reported on Tuesday.
Valisure's analytical laboratory will conduct independent chemical analysis of generic drug products sold by Medly's expanding pharmacy network. The collaboration is intended to allow thousands of patients and healthcare systems in multiple states to have access to Valisure's improved quality assurance.
David Light, CEO and founder of Valisure, was quoted as stating: "The relationship between Valisure and a rapidly growing industry partner like Medly signals to the healthcare community that increased transparency and quality assurance in the global pharmaceutical supply chain is critical now more than ever. With Medly, we have found a like-minded partner who understands and values Valisure's mission of working to independently ensure the quality and safety of the US drug supply and bring this benefit directly to patients."
Par Pharmaceutical starts shipping colchicine 0.6mg capsules
Padagis launces Brinzolamide Ophthalmic Suspension with CGT exclusivity
Novartis completes Sandoz Spin-off
Novartis completes Sandoz spin-off, focusing on innovative medicines
Hikma marks KLOXXADO two-year anniversary by surpassing 375,000 doses donated in the US
STADA seeks full approval for Kinpeygo in IgA nephropathy from UK MHRA
Azurity Pharmaceuticals completes Slayback Pharma acquisition
Sandoz secures European approval for Tyruko biosimilar in MS treatment
Senores Pharmaceuticals introduces Nicardipine Hydrochloride Capsules USP, 20mg and 30mg in US
Lupin collaborates with Mark Cuban Cost Plus Drug Company and COPD foundation
Certara Simcyp receives FDA grants for advanced pharmacokinetic modelling
Sandoz's Tyruko (natalizumab-sztn) gains FDA approval as first biosimilar for relapsing MS
Nephron Pharmaceutical names new chief procurement officer
Lupin Pharmaceuticals launches Tiotropium Bromide Inhalation Powder, 18mcg/capsule in US